Search Medical Condition
Please enter condition
Please choose location

Heart Failure Clinical Trials

A listing of Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (307) clinical trials

Because the most common symptoms of heart failure are also normal signs of aging, such as shortness of breath and fatigue, many people with heart failure are not aware that they have it. Heart failure is a condition that develops slowly as the heart muscle weakens and is forced to ...

Phase N/A

Patients may be entered in the study who are>18 years of age with at least a 30-day history of NYHA Class II to IV HF and and any documented left ventricular ejection fraction within a year prior to screening and signs of volume overload. Patient Inclusion Criteria: History of chronic ...

Phase

This study is designed to assess the efficacy, safety and tolerability of ixmyelocel-T compared to placebo (vehicle control) when administered via transendocardial catheter-based injections to patients with end stage heart failure due to IDCM, who have no reasonable revascularization options (either surgical or percutaneous interventional) likely to provide clinical benefit. ...

Phase

Announcing a new research study of nutritional supplements Specifically, the study will examine whether certain supplements can reduce readmission rates in adults >65 years of age who are hospitalized for the following diagnoses: Heart attack Heart failure COPD Pneumonia

Phase N/A

CRT impant strategy using the longest electrical delay for non-left rundle branh block patients (Enhance CRT). A prospective, randomized.

Phase N/A

Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard diuretic and comorbidity treatment for heart failure with preserved ejection fraction (HFpEF).

Phase N/A

Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard therapy for heart failure with reduced ejection fraction (HFrEF).

Phase N/A

The purpose of this trial or study is to determine if cardiac resynchronization therapy (CRT) can be a benefit to people who have impaired heart function due to past treatment with chemotherapy and/or chest radiation. The investigators are looking to enroll approximately 100 eligible subjects with heart failure in this ...

Phase N/A

This study is being done to compare the effects of bucindolol hydrochloride (bucindolol) to metoprolol succinate (Toprol-XL) on the recurrence of symptomatic atrial fibrillation/atrial flutter in patients with heart failure who have a specific genotype for the beta-1 adrenergic receptor.

Phase